Targeting the signaling in Epstein–Barr virus-associated diseases: mechanism, regulation, and clinical study

Targeting the signaling in Epstein–Barr virus-associated diseases: mechanism, regulation, and clinical study

Abstract Epstein–Barr virus-associated diseases are important global health concerns. As a group I carcinogen, EBV accounts for 1.5% of human malignances, including both epithelial- and lymphatic-originated tumors. Moreover, EBV plays an etiological and pathogenic role in a number of non-neoplastic...

Full description

Bibliographic Details
Main Authors: Ya Cao, Longlong Xie, Feng Shi, Min Tang, Yueshuo Li, Jianmin Hu, Lin Zhao, Luqing Zhao, Xinfang Yu, Xiangjian Luo, Weihua Liao, Ann M. Bode
Format: Article
Language:English
Published: Nature Publishing Group 2021-01-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-020-00376-4

Internet

https://doi.org/10.1038/s41392-020-00376-4

Similar Items